TargetMol

Eldacimibe

Product Code:
 
TAR-T31611
Product Group:
 
Inhibitors and Activators
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20℃
1 / 1
❮❯

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-T31611-1mg1mg£188.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T31611-5mg5mg£352.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T31611-10mg10mg£496.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T31611-25mg25mg£760.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T31611-50mg50mg£1,018.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T31611-100mg100mg£1,348.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T31611-500mg500mg£2,633.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT
How to order with us   Contact us
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Bioactivity:
Eldacimibe is a bio-active chemical. Detailed information has not been published.
CAS:
141993-70-6
Formula:
C39H58N2O5
Molecular Weight:
634.902
Pathway:
Metabolism
Purity:
0.98
SMILES:
CCCCCCN(Cc1ccc(CC(C)(C)C)cc1)C(Nc1cc(c(O)c(c1)C(C)(C)C)C(C)(C)C)=C1C(=O)OC(C)(C)OC1=O
Target:
Acyltransferase

References

Siegfried Hekimi, et al. Acat inhibitors and their use in the prevention or treatment of fibrosis. WO2008058383A1. Chhabria MT, et al. Update on patented cholesterol absorption inhibitors. Expert Opin Ther Pat. 2009;19(8):1083-1107.